StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.76−0.02 (-2.33%)

Close on Nov 20, 2026Market cap $8.93MP/E –Yield –

CytoMed Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 12M, up 0.9% from the year before. The highest annual figure on record is 12M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202512M+0.9%
FY2024Dec 31, 202412M+8.6%
FY2023Dec 31, 202311M+34.3%
FY2022Dec 31, 20228M+14.1%
FY2021Dec 31, 20217M+17.6%
FY2020Dec 31, 20206M–

More CytoMed Therapeutics figures

See a number that looks wrong?